Free pharmaceutical procedural maps built from primary regulatory sources. Every decision point. Every regulatory citation. Designed to be used - in training sessions, at your desk and on the manufacturing floor.
Working in food manufacturing? View the Food GMP Maps →
The free maps on this page cover the full procedural workflow. GMPify subscribers get access to the Enhanced Edition of each map on learn.gmpify.com, with deeper detail built for daily use and inspection prep.
The complete two-phase FDA OOS investigation framework. Phase I laboratory investigation through Phase II full manufacturing investigation. Every decision point, timeline and scope extension requirement from 21 CFR 211.192 and FDA OOS Guidance 2022.
From problem identification through root cause analysis, corrective action implementation and effectiveness verification to closure. Includes VOE design requirements and the 2026 warning letter case patterns.
Deviation classification, impact assessment, root cause methodology selection and CAPA integration. Includes the Apotex 2025 warning letter pattern and 5 Why versus Ishikawa selection criteria.
From change proposal through risk assessment, regulatory classification and implementation to post-implementation review. Includes PAS, CBE-30 and CBE-0 decision logic and ICH Q12 PACMP pathway.
Cleanroom monitoring programme design, alert and action level setting, exceedance investigation and trend analysis. Built from EU GMP Annex 1 2022 and FDA aseptic processing guidance.
From 483 receipt through observation assessment, response drafting, CAPA commitment and follow-up. Includes the March 2026 FDA Draft Guidance requirements and warning letter escalation risk factors.
Three-stage cleaning validation lifecycle from cleaning process design through qualification and continued verification. Includes MACO calculation pathway and HBEL versus legacy limit decision logic.
From batch completion through quality unit review, specification assessment, deviation and OOS status review to release or rejection decision. Covers both FDA and EU GMP qualified person release frameworks.
From supplier identification through qualification assessment, approval, quality agreement and ongoing monitoring. Includes the 2026 contract manufacturing enforcement framework and audit programme requirements.
From product classification through study design, storage condition selection, time point planning and shelf life determination. Built from ICH Q1A(R2) and the 2025 Draft ICH Q1 revision.
From design and specification through testing and certification, documentation and release, to requalification and maintenance. Includes the full ISO class to GMP grade equivalence table. Built from ISO 14644-1:2015, ISO 14644-2:2015, EU GMP Annex 1 2022 and 21 CFR 211.42.
From design and qualification through sampling and testing, trending and review, to maintenance and recertification. Covers PW, WFI and Pure Steam grade requirements. Built from USP <1231>, USP <645>, EU GMP Annex 1 2022 and 21 CFR 211.42.
From sample selection and preparation through test execution, result interpretation and investigation, to release decision and documentation. Covers membrane filtration vs direct inoculation. Built from USP <71>, USP <1071>, EU GMP Annex 1 2022 and 21 CFR 211.167.
From sample and method selection through test execution, result interpretation and trending, to investigation and release decision. Covers the complete USP <1111> product category structure. Built from USP <61>, USP <1111>, EU GMP Annex 1 2022 and 21 CFR 211.113.
From design and planning through execution, incubation and reading, to evaluation and requalification. Covers worst-case design requirements and acceptance criteria. Built from EU GMP Annex 1 2022, FDA Aseptic Processing Guidance 2004, PDA TR 22/28 and ISO 13408-1.
From risk assessment and strategy development through control implementation, monitoring and verification, to review and continuous improvement. Includes the full eight-component CCS framework. Built from EU GMP Annex 1 2022 Section 2.2, ICH Q9(R1) and ICH Q10.
From data collection and baseline through statistical analysis and limit setting, ongoing trend review, to signal response and adjustment. Covers control charts, percentile methods and run rules. Built from EU GMP Annex 1 2022, ICH Q10, USP <1116> and PDA TR 13.
From initial assessment and laboratory investigation through manufacturing and process investigation, root cause and impact assessment, to CAPA and closure. Built on the two-phase model from the Barr decision. Built from 21 CFR 211.192, FDA OOS Guidance 2006 and ICH Q10.
From isolate recovery and triage through method selection and testing, result interpretation and risk assessment, to library management and trending. Covers phenotypic vs genotypic methods. Built from USP <1113>, EU GMP Annex 1 2022 and PDA TR 13.
From detection and criteria through laboratory assessment, process and product investigation, to disposition and programme adjustment. Covers regression analysis, control charts and percent change criteria. Built from ICH Q1E, USP <1010>, 21 CFR 211.166 and 211.192.
From receipt and initial triage through investigation and classification, root cause and impact assessment, to response, CAPA and closure. Covers critical, major and minor complaint classification. Built from 21 CFR 211.198, EU GMP Chapter 8 and ICH Q10.
From audit planning and scheduling through execution, findings documentation and classification, to CAPA and follow-up verification. Covers auditor independence and risk-based scheduling. Built from EU GMP Chapter 9, ICH Q10 and 21 CFR 211.22.
From initiation and planning through identification and analysis, evaluation and control, to communication and review. Covers FMEA, HACCP, Fault Tree Analysis and risk ranking tools. Built from ICH Q9(R1), ICH Q10 and EU GMP Annex 20 / Part III.
From data collection and scope definition through compilation and trend analysis, evaluation and conclusion, to reporting, CAPA and follow-up. Covers required APR content per 21 CFR 211.180(e). Built from 21 CFR 211.180(e), EU GMP Chapter 1 and ICH Q10.
The complete review pathway for executed batch records, from completeness and accuracy checks through deviation and OOS linkage to documented QA review before release.
How to classify a post-approval change, decide the reporting category, and submit it to the right authority, from FDA supplements to EU variations.
The end-to-end clinical trial pathway from protocol and approvals through conduct, safety reporting, and close-out under GCP, with the controls sponsors and sites must apply at each stage.
A risk-based pathway for preventing cross-contamination in shared facilities, from hazard identification and health-based exposure limits to controls, verification, and review.
The structured pathway for investigating a suspected data integrity event, from detection and containment through scope assessment, root cause, and corrective action.
The equipment qualification lifecycle from user requirements and design review through IQ, OQ, PQ, and periodic review, built on a risk-based approach.
What to do before, during, and after an EU GMP inspection, from notification and preparation to the inspection itself, the report, and the response.
The full FDA inspection pathway for drug manufacturers, from arrival and credentials through daily management, Form 483, and the post-inspection response.
The step-by-step gowning sequence for controlled and aseptic areas, with the qualification, behaviour, and monitoring requirements that support it.
The Health Canada GMP inspection pathway for drug establishments, from notification through the inspection, observations, and the response to the inspector.
The line clearance sequence between batches and products, covering removal of materials and documents, verification, and release of the line to start.
How materials move through a GMP facility from receipt and sampling to storage, dispensing, and production without mix-up or contamination.
The analytical method lifecycle from the analytical target profile through validation parameters, system suitability, transfer, and ongoing performance verification.
The monitoring visit pathway from planning and preparation through source data verification, issue escalation, the visit report, and follow-up.
How people move through controlled manufacturing areas, covering entry, gowning, airlock use, and exit to protect product and prevent contamination.
The three-stage process validation lifecycle from process design through qualification to continued process verification.
How to identify, document, classify, and report protocol deviations in a clinical trial, including important deviations and corrective action.
The drug recall pathway from the decision to recall through classification, notification, effectiveness checks, and termination.
The serious adverse event reporting pathway for clinical trials, from site identification through sponsor assessment and expedited reporting to regulators.
The technology transfer pathway from planning and gap assessment through process and method transfer to verification at the receiving site.
Trial master file management from the filing plan and set-up through contemporaneous filing, quality review, and inspection readiness.
How to respond to an FDA warning letter, from the first read and team assembly through investigation, corrective action, and follow-up communication.
Print or display any map during team training to walk through the correct procedural sequence step by step. Every decision point references the applicable regulation so your team understands the why not just the what.
Review the relevant map before an FDA or EU GMP inspection to confirm your procedures align with the regulatory expectations shown at each decision point. Identify gaps before the investigator does.
Each map corresponds to a GMPify course that covers the regulatory content in depth. The map gives you the procedural framework. The course gives you the understanding behind every step.
Each procedural map is built from the same primary regulatory sources as the corresponding GMPify course. The map gives you the framework. The course gives you the regulatory depth, case examples and knowledge checks that prepare you for inspection.